Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVT-E002 in Pediatric URTI
NCT00255307Phase 2Completed
- Sponsor
- CV Technologies
- Start
- Nov 2005
- Modality
- BDS (Botanical Dietary Supplement)
- Countries
- 1
01
Overview
A Phase 2 trial of panax quinquefolius in upper respiratory tract infection (URI), sponsored by CV Technologies. Started Nov 2005; status: completed.
02
Drugs
panax quinquefolius
03
Conditions
upper respiratory tract infection (URI)
Beyond the preview
Go deeper on NCT00255307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00255307.